SHEN Li-qin2 1Department of Nuclear Medicine,the First People's Hospital of Changzhou,Changzhou 213003,China,2Department of Medicine Oncology,the 2nd Affiliated Hospital of Soochow University,Suzhou 215004,China.,.Prognostic factors in patients with stage Ⅳ non-small cell lung cancer.[J];Journal ...
What is non-small cell lung cancer?Non-small cell lung cancer (NSCLC) is the most common type of lung cancer.What are the subtypes of NSCLC?Squamous cell carcinoma is found in cells that line the airways of the lungs. It is usually found in the middle of the lung. Adenocarcinoma is ...
1. Steretacitc radiotherapy(SRT) for Stage I non-small-cell lung cancer(NSCLC); 立体定向放射治疗Ⅰ期非小细胞肺癌临床分析更多例句>> 2) Ⅰ～Ⅱa NSCLC Ⅰ~Ⅱa期非小细胞肺癌 1. Analysis on the Treatment with Pingxiao Capsule for Ⅰ～Ⅱa NSCLC; 平消胶囊对手术后Ⅰ~Ⅱa期非小细胞肺癌...
Surgery plays an important role in the treatment of non–small-cell lung cancer (NSCLC) in the early stages of the disease [1]. However, surgical resection is not actively recommended for patients with stage IV NSCLC presently, despite the fact that systemic therapy has been regarded as the ...
The duration of first-line and the timing of second-line therapy for advanced non-small cell lung cancer has been an area of recent investigation. Five trials have been performed that have investigated shorter (3–4 cycles) versus longer duration of platinum-based therapy; four trials revealed ...
Metastatic disease is responsible for the majority of cancer-related deaths1. We report the longitudinal evolutionary analysis of 126 non-small cell lung cancer (NSCLC) tumours from 421 prospectively recruited patients in TRACERx who developed metas
From a population-based registry analysis of patients with stage I nonsmall cell lung cancer who were treated with definitive radiotherapy, male sex and squamous cell carcinoma histology were found ...
2024肺癌ASCO最新进展之Adjuvant icotinib of 12 months or 6 months versus observationfollowing adjuvant chemotherapy for resected EGFR-mutatedstage ll-lllA non-small-cell lung cancer (ICTAN, GASTO1002) arandomized phase 3 trial.pdf,Adj uvant icotinib of 12
Stage III non-small cell lung cancer: a UK national survey of practicedoi:10.1016/S0169-5002(20)30091-XM. EvisonJ. EdwardsF. McDonaldS. PopatElsevier BVLung Cancer
Figure 4. 10-Year Survival According to Non–Small Cell Lung Cancer Stage at Diagnosis View LargeDownload Table. Demographics and Clinical Characteristics of the Population Under Study View LargeDownload 1. Henley SJ, Ward EM, Scott S, et al. Annual report to the nation on the sta...